These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 1850473)

  • 1. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
    Yue TL; Stadel JM; Sarau HM; Friedman E; Gu JL; Powers DA; Gleason MM; Feuerstein G; Wang HY
    Mol Pharmacol; 1992 Feb; 41(2):281-9. PubMed ID: 1311408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells.
    Lin AY; Rui YC
    Biochim Biophys Acta; 1994 Nov; 1224(2):323-8. PubMed ID: 7981248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
    Barzaghi G; Sarau HM; Mong S
    J Pharmacol Exp Ther; 1989 Feb; 248(2):559-66. PubMed ID: 2537401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells.
    Yue TL; Gleason MM; Hallenbeck J; Feuerstein G
    Neuroscience; 1991; 41(1):177-85. PubMed ID: 2057061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
    Jeanneton O; Delvaux M; Botella A; Frexinos J; Bueno L
    J Pharmacol Exp Ther; 1993 Oct; 267(1):31-7. PubMed ID: 8229757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
    Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
    Yue TL; Rabinovici R; Farhat M; Feuerstein G
    J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
    Saeed SA; Rasheed H
    Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism and regulation of neutrophil priming by platelet-activating factor.
    Gay JC
    J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ; Shukla SD
    J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
    James-Kracke MR; Sexe RB; Shukla SD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):824-31. PubMed ID: 7965802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A; Tahraoui L; Sedivy P; Cavero I
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
    Chen J; Ziboh V; Giri SN
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.